Background: Small-airways instability resulting in premature airway closure has been recognized as a risk for asthma severity and poor control. Although spirometry has limited sensitivity for detecting small-airways dysfunction, a focus on the air-trapping component of obstruction might identify a risk factor for asthma instability. Objective: We sought to use spirometric measurements to identify patterns of airway obstruction in children and define obstruction phenotypes that relate to asthma instability. Methods: Prebronchodilation and postbronchodilation spirometric data were obtained from 560 children in the Asthma Phenotypes in the Inner City study. An air-trapping obstruction phenotype (A Trpg) was defined as a forced vital capacity (FVC) z score of less than 21.64 or an increase in FVC of 10% of predicted value or greater with bronchodilation. The airflow limitation phenotype (A Limit) had an FEV 1 /FVC z score of less than 21.64 but not A Trpg. The no airflow limitation or air-trapping criteria (None) phenotype had neither A Trpg nor A Limit. The 3 obstruction phenotypes were assessed as predictors of number of exacerbations, asthma severity, and airway lability.
Variable airway obstruction is a defining characteristic of asthma, and in recent years, it has become recognized that different patterns of obstruction can have differing associations with asthma severity and instability. Gibbons : Forced expiratory flow rate between 75% and 25% of forced vital capacity FENO: Fraction of exhaled nitric oxide FVC: Forced vital capacity None: No airflow limitation or air-trapping criteria different patterns of response to bronchial challenge, as measured by using spirometry, noting that asthmatic patients with a prominent decrease in forced vital capacity (FVC) associated with a 20% reduction in FEV 1 were more likely to have a history of frequent exacerbations. They proposed the concept that FEV 1 can be partitioned into components of airflow limitation represented as the fraction of vital capacity exhaled in the first second (FEV 1 /FVC ratio) and airway closure represented as a reduction in FVC. 1 The association of premature airway closure and air-trapping with severe asthma and unstable asthma has been reinforced in multiple studies by using physiologic and imaging methods to detect air-trapping during periods of stable asthma. [2] [3] [4] [5] [6] [7] [8] [9] Studies from the Severe Asthma Research Program demonstrated that FEV 1 can be expressed mathematically as a hyperbolic function of its airflow limitation and air-trapping components. 5 This approach revealed that the group with severe asthma had greater air-trapping relative to the group without severe asthma and that a large bronchodilator reversal of FEV 1 was mostly due to a reversal of the air-trapping component. 5 Similarly, the Severe Asthma Research Program children with severe asthma exhibited air-trapping that was mostly reversed with bronchodilator, whereas the group with nonsevere asthma had normal lung residual volume and a bronchodilator response that was reflected only in the airflow limitation component. 6 These studies comparing groups defined by severity suggest that an assessment of airway obstruction patterns also can have value as a prospective marker of asthma instability and severity in individual persons.
The Asthma Phenotypes in the Inner City (APIC) study of the National Institute of Allergy and Infectious Diseases-sponsored Inner City Asthma Consortium evaluated a large set of variables among urban children to identify asthma clusters, factors related to difficulty in achieving asthma control, and the pathways linked to asthma severity. [10] [11] [12] In these analyses the level of airway obstruction, as defined by using FEV 1 percent predicted values, and its reversal with bronchodilation contributed significantly to the models as a risk for severe and difficult-to-control asthma. [10] [11] [12] However, the air-trapping component of obstruction was not assessed in these reports. We hypothesized that a further analysis of APIC data with regard to obstruction patterns would reveal that subjects with an air-trapping phenotype detected by using routine spirometry would exhibit the greatest asthma severity and instability.
METHODS
The APIC study has been described in detail previously. 11 Children aged 6 to 17 years with physician-diagnosed asthma were recruited from low-income census tracts in 9 urban areas. A requirement for enrollment was a history of at least 2 episodes in the past 12 months that were treated with a short-acting b-agonist. After enrollment, participants were followed for 12 months, with visits scheduled every 2 months for clinical assessments and protocol-guided adjustments of treatment based on the Expert Panel Report-3 guidelines. 13 The protocol was approved by institutional review boards from each participating center, and written informed consent was obtained from the legal guardians of participating children.
Defining obstruction phenotypes
Prebronchodilation and postbronchodilation spirometric data from the final (12-month) visit in the APIC study were used to define the obstruction phenotypes. The 2012 Global Lung Initiative reference equations 14 were used to generate predicted values and z scores for FEV 1 , FVC, forced expiratory flow rate between 75% and 25% of forced vital capacity (FEF ), and FEV 1 /FVC ratio. Global Lung Initiative ethnic groupings 1 (white), 2 (black), and 5 (mixed) were assigned based on responses to the APIC demographics questionnaires. The fifth percentile of the healthy population is used conventionally as the lower limit of normal for spirometric variables, which is also a z score of 21.64. We used a z score of less than 21.64 for our definitions for consistency with commercial spirometric software reports that include either lower limit of normal or z score reference points.
Airflow limitation was defined as an FEV 1 /FVC z score of less than 21.64. Air-trapping was defined as an FVC z score of less than 21.64 or a change in FVC with bronchodilation of 10% or greater of predicted value (see Fig E1 in this article's Online Repository at www.jacionline.org). These definitions were based on the concept of partitioning FEV 1 into components of airflow limitation and air-trapping 1, 5 and that the air-trapping component in asthma usually improves after bronchodilation. 5, 6 The cut point of a 10% predicted change in FVC was selected arbitrarily, lacking published guidelines for a minimally important change for this variable. However, a 10% change in FEV 1 with bronchodilation in children has diagnostic specificity for asthma 15 and an association with asthma instability 16 in children. Because FEV 1 changes proportionally with changes in FVC, 5 our cut point for a change in FVC should be meaningful.
Spirometry was performed on standardized equipment by trained technicians and overread centrally by certified pulmonary function technologists to ensure that the measurements conformed to American Thoracic Society guidelines. 11 Before spirometry was performed, the participants were questioned to ensure that they had not had a respiratory tract infection, a cold, or bronchitis in the preceding 4 weeks and that they had not used short-acting bronchodilators within 8 hours or long-acting bronchodilators, anticholinergic agents, leukotriene modifiers, or theophylline within 24 hours.
After baseline spirometry, bronchodilation was achieved with administration of a total of 4 actuations of an albuterol metered-dose inhaler with a valved holding chamber. If the criterion for air-trapping was met, the air-trapping obstruction phenotype (A Trpg) was assigned, and if the airflow limitation but not the air-trapping criteria were met, the airflow limitation phenotype (A Limit) phenotype was assigned. The no airflow limitation or air-trapping criteria (None) phenotype was assigned if neither air-trapping nor airflow limitation criteria were met. Children with both air-trapping and airflow limitation were included in the A Trpg phenotype to reflect the spectrum of airflow patterns associated with air-trapping and to ensure that the number of subjects with air-trapping was sufficient for meaningful statistical analyses.
Other APIC study variables
Blood samples were obtained at the initial visit of the APIC study and processed to obtain blood leukocyte counts, serum total IgE levels, and a panel of 20 allergen-specific IgE concentrations. 11 A panel of 12 common allergens was also applied as skin prick tests. Allergen sensitization was defined as a positive skin prick test response or specific IgE level of greater than 0.35 kU/L, with 22 total allergens tested. 11 Allergen sensitizations were combined further into 7 categories: roaches, pets, rodents, pollens, foods, molds, and dust mites. 11 Serum total IgE levels were used as a log 10 transform in multivariable models.
As an indicator of variability of airway obstruction over time, the SD of FEV 1 percent predicted, as measured across the multiple APIC study visits, was computed for each subject. Methacholine challenge using the tidal breathing method was performed in a subgroup of subjects (n 5 373 in the current analysis), and the provocative concentration of methacholine HCl associated with a 20% decrease in FEV 1 was computed. 12 Methacholine challenges were done at the 8-or 10-month APIC study visit. Plethysmographic lung volumes were measured in a subgroup (n 5 216) at the clinical pulmonary function laboratories at 5 of the study sites during the second 6 months of the APIC study.
All other variables used for the current analyses were determined at the 12-month APIC study visit. FENO values were measured with the NIOX MINO device (Aerocrine, Stockholm, Sweden), as previously described. 11 A cut point of greater than 35 ppb was used to define an increased FENO value. 17 Body mass index (BMI) was computed from height and weight and expressed as the z score. 11 A BMI z score of greater than 1.64 (95th percentile) was used as the definition of obesity. The Composite Asthma Severity Index (CASI) developed by the Inner City Asthma Consortium 18 was used to quantify asthma severity by using domains of daytime and nighttime symptoms and albuterol use, FEV 1 , asthma controller therapy, and exacerbations. A modified CASI score, excluding the FEV 1 domain, was used as a dependent variable in multivariable analysis to avoid redundancy with the spirometry-defined independent variables. The total number of exacerbations requiring a burst of systemic corticosteroid therapy during the 12-month study was recorded. The treatment step attained for each subject at the end of the 12-month study was used as another indicator of asthma severity.
Statistical methods
Summary data for normally distributed variables are presented as means 6 SDs and P values for overall group differences obtained with the general linear model. Nonnormally distributed variables are presented as medians (interquartile ranges), and group differences were tested with the Kruskal-Wallis model. Categorical variables are presented as percentages and compared with the x 2 test. An exploratory analysis was performed to identify variables associated with individual obstruction phenotypes. A multinomial logistic regression model was constructed with an obstruction phenotype as the dependent variable and the None phenotype as the reference category. Independent variables related to demographics, obesity, allergen sensitization, FENO values, and blood eosinophil counts were included in the model and removed in a stepwise manner, minimizing the Akaike information criterion in the final model. This process was repeated for a binary logistic regression model comparing the A Trpg and A Limit phenotypes.
To test the hypothesis that patients with the A Trpg phenotype would have more severe and less stable asthma, we used the categorical obstruction phenotype as an independent variable and indicators of asthma severity and instability as continuous dependent variables. The CASI score modified to exclude the FEV 1 domain and the treatment step attained by the end of the APIC study were used as indicators of severity relative to the obstruction phenotype groups. The number of exacerbations during the APIC study was the primary indicator of asthma instability and tested as both a continuous dependent variable and a binary categorical variable (<2 vs > _2) in a logistic regression model. The SD of FEV 1 percent predicted over multiple APIC study visits and the provocative concentration of methacholine HCl associated with a 20% decrease in FEV 1 were used as indicators of airway lability relative to the obstruction phenotype. Plethysmographic residual lung volumes as a fraction of total lung capacity were compared among the phenotypes. The Kruskal-Wallis test was used to compare each of these variables among the 3 obstruction phenotypes, and the Conover-Inman test was used for post hoc pairwise comparisons, as indicated. Systat software (version 13.1; Systat Software, San Jose, Calif) was used for analyses.
RESULTS
Of the 717 APIC study participants, 594 completed the final scheduled visit of the study, and acceptable prebronchodilation and postbronchodilation spirometric measurements were available for 560. After assigning each subject to one of the obstruction phenotype groups, there were 300 (54%) in the None, 181 (32%) in the A Limit, and 79 (14%) in the A Trpg phenotype groups. Within the A Trpg group, 49 (62%) also met the criteria for airflow limitation, whereas 30 (38%) met the criteria only for air-trapping. Table I summarizes the group characteristics. In addition to the defining spirometric criteria, the None group differed from the other obstruction phenotypes, having a larger proportion of white ethnicity, less obesity, fewer allergen sensitizations, and less inflammation in the univariable comparisons.
Predictably, FEV 1 differed among the groups because it is a global indicator of obstruction that is affected by both airflow limitation and air-trapping. However, FEV 1 was within the normal range for 73% of the A Limit group and 35% of the A Trpg group, indicating that in this population an assessment of the FEV 1 components can add sensitivity to the detection of obstruction.
In the subgroup with plethysmographic lung volume data, patients with the A Trpg phenotype had significantly larger residual lung volume relative to total lung capacity (see Fig E2 in this article's Online Repository at www.jacionline.org), indicating concordance with another measure of air-trapping. Although the plethysmographic measurements were obtained over the previous 6 months, the larger residual volumes within the A Trpg phenotype group defined at the final visit suggests that air-trapping was a persistent feature over time.
We used logistic regression methods to explore demographic characteristics and biomarkers associated with the obstruction phenotypes. Multinomial logistic regression comparing A Limit and A Trpg characteristics relative to the None phenotype revealed that a younger age at asthma diagnosis, obesity, black race, and sensitization to molds were risk factors associated with both A Limit and A Trpg (Table II) . Additionally, a FENO value of greater than 35 ppb was associated with the A Limit group, whereas a higher serum total IgE level and younger current age were associated with the A Trpg group relative to the None group (Table II) . Variables that did not contribute significantly to the model included sex, blood eosinophil count at the initial visit, asthma duration (substituted in the model for age at diagnosis and current age), and the other 6 allergen sensitization categories. Binomial logistic regression modeling of the A Trpg phenotype relative to the A Limit phenotype identified younger age at diagnosis and higher serum total IgE level as significant predictors of the A Trpg phenotype (Table II) .
We next evaluated obstruction phenotype as an independent predictor for indicators of asthma severity and instability. A modified CASI score was computed, excluding the FEV 1 domain to avoid redundancy of spirometric variables in both dependent and independent variables. The A Limit group had higher modified CASI scores than the None group, and the A Trpg group had scores higher than those of both the None and A Limit groups (Fig 1) . A similar pattern was found for treatment step at the final visit (Fig 2) , indicating that obstruction phenotype was related to the intensity of protocol-guided asthma therapy, as well as the current composite severity score. Fig 3 shows the number of exacerbations treated with systemic corticosteroids during the 12-month study period for the 3 obstruction phenotypes, with the ATrpg group having the greatest exacerbation frequency. In a separate analysis of the risk of having 2 or more exacerbations during the study period, odds ratios were 4.41 (95% confidence limit [CL], 2.37-8.21) for the A Trpg phenotype and 2.42 (95% CL, 1.41-4.16) for the A Limit phenotype relative to the None phenotype.
We also evaluated indicators of airway lability (ie, variability of FEV 1 over multiple visits and responsiveness to methacholine challenge) relative to the 3 obstruction phenotypes. Figs 4 and 5 show that patients with the A Trpg phenotype had the greatest variability in FEV 1 over time and were responsive to the lowest concentrations of aerosolized methacholine compared with those Independent variables contributing to the logistic regression model per minimization of the Akaike information criterion are shown.
J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 4 with the A Limit and None phenotypes. Table E1 in this article's Online Repository at www.jacionline.org summarizes these results. FEF might be sensitive to premature airway closure that reduces airflow at lower lung volumes, and therefore we assessed how FEF was associated with the FEV 1 /FVC ratio in subjects with (A Trpg group) and without (A Limit and None groups) air-trapping. Using the z scores of each airflow variable to compare with like scales, the FEF 25-75 z score was highly and linearly correlated with the FEV 1 /FVC z score (R 2 5 0.76, P < .001; see Fig E3 in this article's Online Repository at www.jacionline.org). A comparison of the air-trapping subgroups revealed similar slopes for FEF versus the FEV 1 /FVC ratio and a small negative shift in the intercept when air-trapping is present (FEF 25-75 z score air-trapping effect 5 20.55, P < .001; see Fig E3) . Many of the subjects with air-trapping also had airflow limitation (FEV 1 /FVC z score < 21.64; see Fig E3) . FEF was primarily an indicator of airflow limitation, measuring a value less than the lower limit of normal for only a small proportion of the air-trapping group having FEV 1 /FVC ratios within the normal range (see Fig E3, lower right quadrant) . Thus FEF is slightly more sensitive than FEV 1 /FVC ratio for detection of the effects of premature airway closure on airflow limitation, but neither variable functions as a selective indicator of airway closure.
DISCUSSION
The data show that in a cohort of inner-city children with protocol-guided asthma treatment, those meeting spirometric criteria for air-trapping require higher levels of treatment, experience more exacerbations, and have more airway lability compared with those who have airflow limitation without air-trapping and those with normal spirometric results at the time of evaluation. Collectively, our data strongly support the notion that air-trapping is an indicator of severe asthma in children.
Although air-trapping, as measured with plethysmography, has been demonstrated in groups of children classified as having severe asthma, 6, 8 this is the first study to define an air-trapping phenotype in individual children by using routine spirometric measurements and bronchodilation. In a comparison of groups of adults with an unstable versus stable asthma history but similar FEV 1 , premature airway closure, measured with single-breath nitrogen washout, was the distinguishing physiologic difference between the groups. 3 Similarly, in the current study the A Trpg and A Limit phenotypes did not differ with regard to FEV 1 /FVC ratio (Table I) , but the presence of detectable air-trapping identified children with increased risk of exacerbations and a need for more intense therapy.
Our results are consistent also with studies in children showing that oscillometric indicators of small airway dysfunction are associated with poor asthma control. 19, 20 The association of air-trapping with methacholine responsiveness is also consistent with the studies of Pyrgos et al, 21 reporting that baseline air-trapping in adults was associated quantitatively with an attenuation of the protective effect of deep inflation on the methacholine response.
Our definition of air-trapping is based on reduced FVC, which is an indicator of increased lung residual volume, providing that total lung capacity is not reduced substantially. Although total lung capacity can be increased in the setting of childhood asthma, 22 a reduction in lung size is not likely to be associated with asthma. However, in many persons a decrease in FVC can occur without resulting in measured FVC of less than the lower limit of normal, making this criterion for air-trapping relatively insensitive. One feature of asthma is the reversibility of obstruction with bronchodilators, and when airway closure contributes to the obstruction, there also can be reversal of that component of the obstruction, resulting in an increase in FVC. 5 Thus an increase in FVC after bronchodilation implies that air-trapping was present at baseline and that airway smooth muscle tone contributed to the closure. This is in contrast to other potential factors causing reduced FVC, such as reduced lung recoil force, restrictive lung disease, mucous plugging, tracheal-bronchial malacia, or paradoxical vocal fold motion, which are not influenced by acute b-agonist inhalation.
In the current study of children, the subjects with the lowest FEV 1 /FVC z score also exhibited air-trapping, although a subgroup of those with air-trapping had normal FEV 1 /FVC ratios (see Fig E3) . The FEV 1 /FVC ratio is a commonly used indicator of airway obstruction. FVC is the limiting volume for FEV 1 , and thus the ratio is a meaningful conversion of flow units for FEV 1 from liters per second to vital capacities per second given that FEV 1 is a timed expiratory volume. This conversion of units also normalizes FEV 1 to the available vital capacity, which reduces intrasubject variability, but there are significant effects of age, sex, race, and height that can be factored into the predictive equations and z scores.
14 When FVC is normal, reduced airflow can be interpreted as reduced airway conductance or reduced caliber, assuming the lung elastic recoil is normal. 23 Airway closure will decrease FVC, reducing the denominator of the FEV 1 /FVC ratio, but it also will interrupt airflow, reducing the numerator of the ratio. The ultimate effect on the ratio will depend on the pattern of airway closure. If airway closure occurs mainly after the initial 1 second of forced expiration, the numerator and denominator can be reduced proportionally, resulting in a normal ratio. However, earlier airway closure during forced expiration might make a greater contribution to reducing airflow in the first second, resulting in a lower FEV 1 /FVC ratio. In adults with severe asthma, there was a parallel decrease in FVC percent predicted and FEV 1 /FVC percent predicted, whereas in those with nonsevere asthma, FEV 1 /FVC percent predicted was not associated with changes in FVC, indicating different patterns of airway instability. 5 Quanjer et al 24 analyzed data from a large number of spirometric records from clinical pulmonary function assessments to determine whether FEF was likely to detect airflow abnormalities when FEV 1 , FVC, and FEV 1 /FVC ratio were all within the normal range. Using z scores to set lower limits of normal at the 5th percentile, they reported that FEF and FEV 1 /FVC z scores were highly correlated and that when FEV 1 , FVC, and FEV 1 /FVC values were within the normal range, less than 3% of FEF measurements were less than normal. They concluded that FEF does not offer diagnostic sensitivity or specificity over the other standard spirometric variables. Our data are in agreement with these conclusions, finding that FEF is primarily a measure of airflow limitation that is highly correlated with FEV 1 /FVC ratio (see Fig E3) . There is a small negative shift in the intercept of the FEF versus FEV 1 /FVC z score plot in the subgroup with air-trapping that captured a small number of subjects with air-trapping and low FEF but in the normal range of FEV 1 /FVC (see Fig E3) . However, the majority of subjects with air-trapping and normal FEV 1 /FVC ratios also had normal FEF , suggesting that although it can be affected by premature airway closure, FEF is not likely to provide additional information about obstruction patterns. One reason for a limited effect of airway closure on FEF is that a truncated FVC will shift the volume range at which FEF 25-75 is measured to a higher lung volume relative to total lung capacity, at which maximal flow rates will be higher. Our exploratory analysis of factors associated with the obstruction phenotypes identified several potential predictors of the A Limit and A Trpg phenotypes relative to the None phenotype (Table II) . In multivariable analyses higher serum IgE levels and lower age of asthma diagnosis were the strongest predictors of the A Trpg phenotype relative to the other obstruction phenotypes. The univariable comparisons (Table I) also were indicative of the strong allergy component in the A Trpg group, with the highest levels of allergen sensitization and blood eosinophil counts, as well as the highest serum total IgE levels, in that phenotype. In the previous APIC study analyses, serum IgE levels, sensitization to molds, age at asthma diagnosis, and BMI z scores were identified also as important distinguishing characteristics of difficult-to-treat versus easy-totreat subgroups. 11 Premature airway closure resulting in air-trapping is most likely to occur in small membranous airways 25 and thus is among the indicators that have been used to assess small-airway dysfunction in asthmatic patients. 7 Airway closure is the most extreme case of airway narrowing and an indicator of airway instability. 25, 26 The current study supports the idea that the presence of air-trapping during a stable period is a marker of airway instability that is likely to result in difficult-to-control asthma. Although the underlying causes of small-airways instability are poorly understood, improvement in air-trapping acutely with b-agonist treatment and after a course of anti-inflammatory drug therapy 9 suggest that it might be possible to design therapy that can prevent or reverse this insidious form of airway obstruction.
In conclusion, using routine spirometry and bronchodilator response, an air-trapping obstruction pattern can be identified in a subgroup of children with asthma. This obstruction phenotype has characteristics of greater asthma severity and instability and requires more intensive therapy compared with those with normal spirometric results or airflow limitation without air-trapping during a stable period. Importantly, this is a method by which a high-risk asthma group can be identified prospectively using measurements that are safe, inexpensive, easy to perform, and widely available to clinicians. Having additional information regarding the risk of asthma instability should be useful to clinicians for making decisions regarding choice of controller therapy, advancing therapy to a higher step, and formulating an action plan for exacerbations. The results support the concept that small-airways instability, manifesting as airway closure, is an important component of asthma pathophysiology. Why this phenotype develops in childhood, how it relates to asthma severity and control over time, and how best to treat it are questions that remain to be addressed in future investigations.
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Clinical implications: Small-airways dysfunction can be detected as air-trapping with routine spirometric measures and can identify greater risk for asthma severity and instability in children. 
